Companies: 10,795·Total market cap: $144.5T
Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc.

RIGLNASDAQHealthcare● Active
$30.08
+$0.15(+0.50%)
Market Cap$556542566
P/E Ratio
52W High$52.24
52W Low$18.14
Overview

Rigel Pharmaceuticals, Inc. (RIGL) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · RIGL · as of Mar 3, 2026

Latest filing snapshot

172
+10+6.17%vs prior year

Rigel Pharmaceuticals, Inc. (RIGL) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
172
Change (1Y)
+10
Growth % (1Y)
+6.17%
Revenue / Employee
$1.71M
Net Income / Employee
$2.13M
Market Cap
$557M

RIGL Employee Count

2000 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-03172+10+6.17%
2025-03-04162+15+10.20%
2024-03-05147-8-5.16%
2023-03-07155-10-6.06%
2022-03-01165-4-2.37%
2021-03-02169+6+3.68%
2020-02-27163+5+3.16%
2019-02-28158+55+53.40%
2018-03-06103+26+33.77%
2017-03-0777-49-38.89%

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Bicycle Therapeutics plc
BCYC
Bicycle Therapeutics plc
305
#2
4D Molecular Therapeutics, Inc.
FDMT
4D Molecular Therapeutics, Inc.
227
#3
Akebia Therapeutics, Inc.
AKBA
Akebia Therapeutics, Inc.
181
#4
Rigel Pharmaceuticals, Inc.
RIGL
Rigel Pharmaceuticals, Inc.YOU
172
#5
KalVista Pharmaceuticals, Inc.
KALV
KalVista Pharmaceuticals, Inc.
150
#6
Gossamer Bio, Inc.
GOSS
Gossamer Bio, Inc.
144
#7
Corvus Pharmaceuticals, Inc.
CRVS
Corvus Pharmaceuticals, Inc.
31
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · RIGL peer comparison

About RIGL employees

RIGL Employees · Headcount

Rigel Pharmaceuticals, Inc. (RIGL) employee data is sourced from the annual SEC 10-K filing. As of 2025, Rigel Pharmaceuticals, Inc. had 172 full-time employees globally. Full-time employees only. Global consolidated headcount.

Rigel Pharmaceuticals, Inc. employs 172 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.71M, reflecting the company's operational efficiency.

Rigel Pharmaceuticals, Inc.'s workforce increased by 10 (6.17%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Rigel Pharmaceuticals, Inc.'s revenue per employee of $1.71M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

RIGL Employees · 5 questions

As of the latest SEC 10-K filing (2025), Rigel Pharmaceuticals, Inc. had 172 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Rigel Pharmaceuticals, Inc. employee counthow many employees does Rigel Pharmaceuticals, Inc. haveRIGL total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-03